Diffusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

CervoMed

14/05/2022 01:16

* Diffusion Pharmaceuticals Inc  DFFN.OQ  reported a
quarterly
adjusted loss of $2.22​​ per share for the quarter ended in
March. The mean expectation of two analysts for the quarter was
for a loss of $2.00 per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Diffusion Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of $2.22​.
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Diffusion Pharmaceuticals Inc shares had fallen by 46.3%
this
quarter and lost 56.0% so far this year.
    * The company reported a quarterly loss of $4.53 million.
    * Wall Street's median 12-month price target for Diffusion
Pharmaceuticals Inc is $100.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 14 at 12:16 a.m.  ​All
figures in US dollars unless otherwise stated